Boris Fehse Selected Research

Chemokine Receptors

1/2021

Automated production of CCR5-negative CD4+-T cells in a GMP-compatible, clinical scale for treatment of HIV-positive patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Boris Fehse Research Topics

Disease

34	Neoplasms (Cancer) 12/2023 - 12/2004
13	Primary Myelofibrosis (Myelosclerosis) 07/2023 - 03/2005
12	Multiple Myeloma 01/2020 - 08/2002
6	Neoplasm Metastasis (Metastasis) 12/2023 - 04/2012
6	Leukemia 03/2022 - 06/2005
6	Infections 01/2021 - 05/2010
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2013 - 08/2002
5	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 08/2008
4	Residual Neoplasm 01/2022 - 05/2006
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2013 - 01/2009
3	Disease Progression 03/2024 - 01/2011
3	Multiple Sclerosis 03/2024 - 01/2016
3	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 01/2019
3	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 05/2015
3	B-Cell Lymphoma (Lymphoma, B Cell) 12/2021 - 03/2020
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021 - 08/2008
3	Lymphoma (Lymphomas) 01/2021 - 12/2004
2	cell-associated neurotoxicity 01/2023 - 12/2021
2	Body Weight (Weight, Body) 05/2022 - 08/2008
2	Thrombocytopenia (Thrombopenia) 12/2021 - 12/2021
2	HIV Infections (HIV Infection) 01/2021 - 01/2013
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2013
2	Glioma (Gliomas) 11/2019 - 12/2010
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018 - 01/2014
2	Breast Neoplasms (Breast Cancer) 03/2015 - 12/2010
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2011 - 01/2008
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2024
1	Liver Neoplasms (Liver Cancer) 12/2023
1	Pathologic Constriction (Stenosis) 10/2023
1	Liver Diseases (Liver Disease) 10/2023
1	Sclerosing Cholangitis 10/2023
1	COVID-19 01/2022
1	Inflammation (Inflammations) 12/2021
1	Neutropenia 12/2021
1	Cytokine Release Syndrome 12/2021
1	Thrombosis (Thrombus) 12/2021

Drug/Important Bio-Agent (IBA)

7	AntibodiesIBA 12/2023 - 05/2015
6	Proteins (Proteins, Gene)FDA Link 12/2023 - 06/2005
6	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 08/2008 - 12/2002
5	Chimeric Antigen ReceptorsIBA 03/2024 - 01/2020
4	axicabtagene ciloleucelIBA 05/2022 - 03/2020
4	EpitopesIBA 01/2020 - 06/2013
4	ErbB Receptors (EGF Receptor)IBA 11/2019 - 05/2015
3	CytokinesIBA 12/2023 - 04/2012
3	Busulfan (Busulfex)FDA Link 05/2022 - 03/2005
3	VaccinesIBA 01/2022 - 12/2021
3	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2017
3	Thymidine KinaseIBA 11/2019 - 12/2004
3	ProdrugsIBA 11/2019 - 01/2013
3	Cetuximab (Erbitux)FDA Link 01/2019 - 05/2015
3	AntigensIBA 01/2016 - 01/2013
2	CD19-specific chimeric antigen receptorIBA 01/2023 - 07/2020
2	tisagenlecleucelIBA 05/2022 - 12/2021
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
2	Messenger RNA (mRNA)IBA 01/2021 - 12/2017
2	Monoclonal AntibodiesIBA 01/2020 - 08/2014
2	EnzymesIBA 01/2020 - 12/2015
2	Ganciclovir (Cytovene)FDA LinkGeneric 11/2019 - 12/2004
2	Panitumumab (Vectibix)FDA Link 01/2019 - 05/2015
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2016 - 06/2013
2	Ciliary Neurotrophic Factor (CNTF)IBA 09/2014 - 12/2013
2	fludarabineIBA 03/2005 - 12/2002
1	Sorafenib (BAY 43-9006)FDA Link 12/2023
1	GoldIBA 12/2023
1	Interferon-alpha (Interferon Alfa)IBA 12/2023
1	Fluorouracil (Carac)FDA LinkGeneric 12/2023
1	Interleukin-10 ReceptorsIBA 12/2023
1	Axitinib (AG 013736)IBA 12/2023
1	Interleukin-10 (Interleukin 10)IBA 12/2023
1	HLA-DPA1 antigen (HLA DPA1)IBA 10/2023
1	sulfolaneIBA 05/2022
1	Glutathione Transferase (Glutathione S-Transferase)IBA 05/2022
1	Epithelial Cell Adhesion MoleculeIBA 04/2022
1	Surface Antigens (Surface Antigen)IBA 04/2022
1	p38 Mitogen-Activated Protein KinasesIBA 04/2022
1	MTOR InhibitorsIBA 04/2022
1	C-Reactive ProteinIBA 12/2021
1	Hemoglobins (Hemoglobin)IBA 12/2021
1	Ferritins (Ferritin)IBA 12/2021
1	Heparin (Liquaemin)FDA LinkGeneric 12/2021
1	ChAdOx1 nCoV-19IBA 12/2021
1	COVID-19 VaccinesIBA 12/2021
1	CCR5 Receptors (CCR5 Receptor)IBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	Transcription Activator-Like EffectorsIBA 01/2021
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2021
1	Signaling Lymphocytic Activation Molecule FamilyIBA 01/2021
1	Transcription Activator-Like Effector NucleasesIBA 01/2021
1	Chemokine ReceptorsIBA 01/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2021

Therapy/Procedure

21	Stem Cell Transplantation 01/2023 - 08/2002
19	Therapeutics 03/2024 - 12/2005
12	Transplantation 12/2023 - 12/2002
6	Hematopoietic Stem Cell Transplantation 05/2022 - 12/2010
5	Drug Therapy (Chemotherapy) 01/2021 - 12/2010
4	Immunotherapy 12/2023 - 07/2009
3	Homologous Transplantation 09/2010 - 11/2004
1	Immunomodulation 03/2024
1	Liver Transplantation 10/2023
1	Cell Transplantation 07/2023